Treponema pallidum-specific immune responses and autoimmunity in patients who remain serofast after treatment of syphilis

Abstract

We demonstrate that baseline antigen-specific immune response to Treponema pallidum may be an important predictor of the treatment outcome. Further studies are warranted to identify the role of autoimmunity in the pathomechanism of the serofast state.